News Coverage 07.23.19 By: Amber Tong Share on Twitter Share on Facebook Share on LinkedIn PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Related Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat